1 Item 1A. Risk Factors 37 Item 1B. Unresolved Staff Comments 72 Item 1C. Cybersecurity 72 Item 2. Properties 73 Item 3. Legal Proceedings 74 Item 4. Mine Safety Disclosures 74 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 75 Item 6. Reserved 75 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 76 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 87 Item 8. F...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-19 | 2025-12-31 | 0001193125-26-115922 | EDGAR | 91K words |
| 2025-03-19 | 2024-12-31 | 0000950170-25-041981 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0000950170-24-028610 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006807 | EDGAR | — |
| 2022-02-17 | 2021-12-31 | 0001564590-22-005569 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001564590-21-015916 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-269426 | EDGAR | 21K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-102963 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066884 | EDGAR | — |
| 2024-11-01 | 2024-09-30 | 0000950170-24-119809 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095383 | EDGAR | — |
| 2024-04-29 | 2024-03-31 | 0000950170-24-049808 | EDGAR | — |
| 2023-11-06 | 2023-09-30 | 0000950170-23-059367 | EDGAR | — |
| 2023-07-31 | 2023-06-30 | 0000950170-23-035925 | EDGAR | — |
| 2023-04-28 | 2023-03-31 | 0000950170-23-015461 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-022935 | EDGAR | — |
| 2022-07-29 | 2022-06-30 | 0000950170-22-013434 | EDGAR | — |
| 2022-04-29 | 2022-03-31 | 0000950170-22-006612 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-23 | 0001193125-26-118699 | EDGAR | 6K words |
| 2026-03-10 | 0001193125-26-099404 | EDGAR | — |
| 2026-02-11 | 0001193125-26-046817 | EDGAR | — |
| 2026-02-10 | 0001193125-26-043741 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009812 | EDGAR | — |
| 2026-01-06 | 0001193125-26-003490 | EDGAR | — |
| 2025-11-10 | 0001193125-25-273342 | EDGAR | — |
| 2025-06-20 | 0000950170-25-088168 | EDGAR | — |
| 2024-10-15 | 0000950170-24-114481 | EDGAR | — |
| 2024-10-07 | 0000950170-24-113091 | EDGAR | — |
73 total filings indexed. 45 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001800315 |
| Ticker | DMRA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.damoratx.com |
| Listed | 2020-10-29 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report